Rapid desensitization of the TRH receptor and persistent desensitization of its constitutively active mutant
- PMID: 10807668
- PMCID: PMC1572060
- DOI: 10.1038/sj.bjp.0703291
Rapid desensitization of the TRH receptor and persistent desensitization of its constitutively active mutant
Abstract
We studied rapid desensitization of the thyrotropin-releasing hormone receptor (TRH-R) or the m1-muscarinic receptor (m1-R) to a short challenge of threshold TRH concentration and persistent desensitization due to constitutive activity of a mutant TRH-R. Xenopus oocytes expressing TRH-Rs and/or m1-Rs were challenged for 15 s with threshold concentrations of TRH ([TRH]) and then immediately with supraoptimal [TRH] or acetylcholine ([ACh]). The threshold challenge caused desensitization of 50 - 57% of responses to subsequent supraoptimal stimulation with TRH or ACh. The homologous desensitization was reversible within 60 s after removal of the agonist. The protein kinase C (PKC) inhibitor, chelerythrine, inhibited the control responses by 30 - 40%, without affecting the desensitized responses. Chelerythrine or the phosphatase inhibitor, okadaic acid, had little effect on the kinetics of resensitization, indicating limited involvement of PKC. In oocytes coexpressing wild type TRH-Rs or m1-Rs with a constitutively active TRH-R mutant (C335Stop TRH-R), a persistent desensitization (33 - 57%) of the responses to TRH or ACh was observed. Additionally, there was a complete loss of the rapid desensitization induced by threshold [TRH]. Chlorodiazepoxide (CDE), a competitive binding antagonist of TRH-Rs and an inverse agonist of C335Stop TRH-Rs, abolished the persistent desensitization induced by C335Stop TRH-Rs and enabled the rapid desensitization, conferring the wild type phenotype on C335Stop TRH-Rs. Chelerythrine had qualitatively the same effect as CDE. In conclusion, unlike the rapid desensitization, the persistent desensitization caused by the constitutively active C335Stop TRH-Rs is largely mediated by PKC. It abrogates, however, the rapid desensitization, suggesting a common mechanistic step(s).
Figures






Similar articles
-
Inverse agonist abolishes desensitization of a constitutively active mutant of thyrotropin-releasing hormone receptor: role of cellular calcium and protein kinase C.Br J Pharmacol. 1999 Mar;126(5):1097-106. doi: 10.1038/sj.bjp.0702415. Br J Pharmacol. 1999. PMID: 10204996 Free PMC article.
-
A constitutively active mutant thyrotropin-releasing hormone receptor is chronically down-regulated in pituitary cells: evidence using chlordiazepoxide as a negative antagonist.Mol Endocrinol. 1995 Nov;9(11):1455-60. doi: 10.1210/mend.9.11.8584022. Mol Endocrinol. 1995. PMID: 8584022
-
Truncation of the thyrotropin-releasing hormone receptor carboxyl tail causes constitutive activity and leads to impaired responsiveness in Xenopus oocytes and AtT20 cells.J Biol Chem. 1995 Jan 20;270(3):1041-7. doi: 10.1074/jbc.270.3.1041. J Biol Chem. 1995. PMID: 7836357
-
Molecular and cellular biology of thyrotropin-releasing hormone receptors.Physiol Rev. 1996 Jan;76(1):175-91. doi: 10.1152/physrev.1996.76.1.175. Physiol Rev. 1996. PMID: 8592728 Review.
-
In situ hybridization localization of TRH precursor and TRH receptor mRNAs in the brain and pituitary of Xenopus laevis.Ann N Y Acad Sci. 2005 Apr;1040:95-105. doi: 10.1196/annals.1327.012. Ann N Y Acad Sci. 2005. PMID: 15891012 Review.
Cited by
-
Biochemical and physiological insights into TRH receptor-mediated signaling.Front Cell Dev Biol. 2022 Sep 6;10:981452. doi: 10.3389/fcell.2022.981452. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36147745 Free PMC article. Review.
-
Long-QT mutations in KCNE1 modulate the 17β-estradiol response of Kv7.1/KCNE1.Sci Adv. 2023 Mar 17;9(11):eade7109. doi: 10.1126/sciadv.ade7109. Epub 2023 Mar 15. Sci Adv. 2023. PMID: 36921038 Free PMC article.
-
The human 5-HT7 serotonin receptor splice variants: constitutive activity and inverse agonist effects.Br J Pharmacol. 2002 Mar;135(6):1563-71. doi: 10.1038/sj.bjp.0704588. Br J Pharmacol. 2002. PMID: 11906971 Free PMC article.
-
Excitatory effects of thyrotropin-releasing hormone in the thalamus.J Neurosci. 2005 Feb 16;25(7):1664-73. doi: 10.1523/JNEUROSCI.3198-04.2005. J Neurosci. 2005. PMID: 15716402 Free PMC article.
References
-
- ARVANITAKIS L., GERAS-RAAKA E., GERSHENGORN M.C. Constitutively signaling G-protein-coupled receptors and human disease. Trends Endocrinol. Metabol. 1998;9:27–31. - PubMed
-
- BARAK L.S., WARABI K., FENG X., CARON M.G., KWARTA M.M. Real-time visualization of cellular redistribution of G protein-coupled receptor kinase 2 and β-arrestin 2 during homologous desensitization of substance P receptor. J. Biol. Chem. 1999;274:7565–7569. - PubMed
-
- HEINFLINK M., NUSSENZVEIG D.R., GRIMBERG H., LUPU-MEIRI M., ORON Y., GERSHENGORN M.C. A constitutively active mutant thyrotropin-releasing hormone receptor is chronically down-regulated in pituitary cells: Evidence using chlorodiazepoxide as a negative antagonist. Mol. Endocrinol. 1995;9:1455–1460. - PubMed
-
- JINISI-PARIMOO A., GERSHENGORN M.G. Constitutive activity of native thyrotropin-releasing hormone receptors revealed using a protein kinase C-responsive reporter gene. Endocrinology. 1997;138:1471–1475. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources